U.S. Markets close in 51 mins

Mustang Bio, Inc. (MBIO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.2200-0.0300 (-1.33%)
As of 04:00PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.2500
Bid2.2100 x 28000
Ask2.2300 x 1300
Day's Range2.1800 - 2.3100
52 Week Range1.9900 - 5.2200
Avg. Volume982,011
Market Cap193.836M
Beta (5Y Monthly)1.71
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    3 Penny Stocks Insiders Are Buying

    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Dakota Territory Resource The Trade: Dakota Territory Resource Corp. (OTC: DTRC) President and CEO Jonathan Awde acquired

  • Benzinga

    Mustang Bio Secures $2M NIH Grant For CAR T Cell Therapy Development

    Mustang Bio Inc (NASDAQ: MBIO) has been awarded a grant of approximately million from the National Cancer Institute of the National Institutes of Health (NIH). The two-year award will partially fund the Phase 1 trial to assess the safety, tolerability, and efficacy of MB-106 for relapsed or refractory B-cell non-Hodgkin lymphomas or chronic lymphocytic leukemia. MB-106 is a CD20-targeted, autologous CAR T cell therapy. Related: Mustang Bio's CAR T Cell Therapy Achieves 93% ORR, 67% CR In Mid-Sta

  • Simply Wall St.

    Here's What Mustang Bio, Inc.'s (NASDAQ:MBIO) Shareholder Ownership Structure Looks Like

    The big shareholder groups in Mustang Bio, Inc. ( NASDAQ:MBIO ) have power over the company. Institutions often own...